KEGG   DISEASE: Chronic arterial occlusive disease
Entry
H01629                      Disease                                

Name
Chronic arterial occlusive disease
  Subgroup
Arteriosclerosis obliterans [DS:H01626]
Buerger disease [DS:H01625]
Description
Chronic arterial occlusive disease is a highly prevalent peripheral vascular disorder. This disease is caused by arteriosclerosis obliterans (ASO), thromboangiitis obliterans (Buerger's disease), primary arterial thrombosis, embolism and so on. Of these, ASO is the most frequently encountered. Although differing clinically and pathologically, these diseases are similar in that they cause ischemia of tissues. The symptoms of chronic occlusive arterial disease result from impairment of blood flow to the extremities. Intermittent claudication is the commonest and usually the earliest symptom.
Category
Vascular disease
Brite
Human diseases [BR:br08402]
 Cardiovascular diseases
  Vascular diseases
   H01629  Chronic arterial occlusive disease
Human diseases in ICD-11 classification [BR:br08403]
 11 Diseases of the circulatory system
  Diseases of arteries or arterioles
   Chronic arterial occlusive disease
    BD40  Atherosclerotic chronic arterial occlusive disease
     H01629  Chronic arterial occlusive disease
    BD41  Non-atherosclerotic chronic arterial occlusive disease
     H01629  Chronic arterial occlusive disease
    BD42  Raynaud phenomenon
     H01629  Chronic arterial occlusive disease
Drug
Pentoxifylline [DR:D00501]
Comment
See also H01625 Buerger's disease and H01626 Arteriosclerosis obliterans.
Other DBs
ICD-11: BD40 BD41 BD42
ICD-10: I74
MeSH: D001157
Reference
  Authors
JUERGENS JL
  Title
Chronic occlusive arterial disease of the extremities.
  Journal
Circulation 27:964-9 (1963)
DOI:10.1161/01.CIR.27.5.964
Reference
  Authors
Idei N, Nishioka K, Soga J, Hidaka T, Hata T, Fujii Y, Fujimura N, Maruhashi T, Mikami S, Teragawa H, Kihara Y, Noma K, Chayama K, Higashi Y
  Title
Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger's disease) and atherosclerosis obliterans.
  Journal
Hypertension 57:70-8 (2011)
DOI:10.1161/HYPERTENSIONAHA.110.163683
Reference
PMID:10908215 (drug)
  Authors
Lievre M, Morand S, Besse B, Fiessinger JN, Boissel JP
  Title
Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group.
  Journal
Circulation 102:426-31 (2000)
DOI:10.1161/01.CIR.102.4.426

» Japanese version

DBGET integrated database retrieval system